|
Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 113-116
|
Chemoradiotherapy in non-small cell lung cancer: Paclitaxel/carboplatin/radiotherapy in regionally advanced disease
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SCREENING;
ESOPHAGITIS;
HUMAN;
LUNG NON SMALL CELL CANCER;
MUCOSA INFLAMMATION;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
ESOPHAGITIS;
HUMANS;
LUNG NEOPLASMS;
MIDDLE AGED;
MUCOUS MEMBRANE;
NEUTROPENIA;
PACLITAXEL;
RADIATION-SENSITIZING AGENTS;
SURVIVAL RATE;
|
EID: 0030476666
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (20)
|
References (15)
|